Patents Represented by Attorney David R. Resnick
  • Patent number: 5843737
    Abstract: We have now discovered that eukaryotes, including mammals, have a gene that encodes a multifunctional protein having helicase activity, DNA repair activity, p53 sequestering activity and oncogenetic transformation potential. Enhanced transcripts and expression of this gene in non-testicular cells have a high correlation to disease state in a number of cancers, such as colorectal carcinomas, hereditary cancers resulting from defects in DNA repair pathways, breast cancers, etc. Accordingly, discovering enhanced levels of transcript or gene product in non-testicular tissues can be diagnostic of a predisposition to cancer, and prognostic for a particular cancer.
    Type: Grant
    Filed: December 30, 1994
    Date of Patent: December 1, 1998
    Inventors: Lan Bo Chen, Shideng Bao
  • Patent number: 5135919
    Abstract: Fumagillin and its salts have an angiogenesis inhibiting activity and are useful for prophylaxis and treatment of diseases induced by abnormally stimulated neovascularization. The invention also provides certain pharmaceutical compositions comprising fumagillin or its salt, and an agent which potentiates angiogenesis inhibition such as heparin and sulfated cyclodextrins such as beta-cyclodextrin tetradecasulfate.
    Type: Grant
    Filed: March 25, 1988
    Date of Patent: August 4, 1992
    Assignees: Children's Medical Center Corporation, Takeda Chemical Industries, Ltd.
    Inventors: Judah Folkman, Takeshi Fujita, Donald Ingber, Tsuneo Kanamaru